Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Sparano

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
JAMA Oncology|February 22, 2019
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer-In ReplyJoseph A Sparano
JAMA Oncology|February 14, 2020
Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer-ReplyJoseph A Sparano
Current Opinion in Oncology|September 1, 2007
HIV-associated lymphoma: the evidence for treating aggressively but with cautionJoseph A Sparano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Defining a role and predicting benefit from platinum-based therapy in breast cancer: an evolving storyJoseph A Sparano
JAMA Oncology|January 13, 2018
Neoadjuvant Systemic Therapy for Breast Cancer: Searching for More Effectively Curative TherapiesJoseph A Sparano
NPJ Breast Cancer|May 31, 2018
Prognostic gene expression assays in breast cancer: are two better than one?Joseph A Sparano
Breast Cancer Research and Treatment|April 7, 2010
Is there a role for ovarian function suppression in operable breast cancer?Joseph A Sparano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2024
Development and Validation of Data-Driven Estimates of Recurrence Risk and Treatment Benefit in Early Breast CancerJoseph A Sparano
The New England Journal of Medicine|April 7, 2016
A 21-Gene Expression Assay in Breast CancerJoseph A Sparano
Current Opinion in Oncology|September 10, 2003
Human immunodeficiency virus associated lymphomaJoseph A Sparano
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
JAMA Oncology|February 22, 2019
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer-In ReplyJoseph A Sparano
JAMA Oncology|February 14, 2020
Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer-ReplyJoseph A Sparano
Current Opinion in Oncology|September 1, 2007
HIV-associated lymphoma: the evidence for treating aggressively but with cautionJoseph A Sparano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Defining a role and predicting benefit from platinum-based therapy in breast cancer: an evolving storyJoseph A Sparano
JAMA Oncology|January 13, 2018
Neoadjuvant Systemic Therapy for Breast Cancer: Searching for More Effectively Curative TherapiesJoseph A Sparano
NPJ Breast Cancer|May 31, 2018
Prognostic gene expression assays in breast cancer: are two better than one?Joseph A Sparano
Breast Cancer Research and Treatment|April 7, 2010
Is there a role for ovarian function suppression in operable breast cancer?Joseph A Sparano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2024
Development and Validation of Data-Driven Estimates of Recurrence Risk and Treatment Benefit in Early Breast CancerJoseph A Sparano
The New England Journal of Medicine|April 7, 2016
A 21-Gene Expression Assay in Breast CancerJoseph A Sparano
Current Opinion in Oncology|September 10, 2003
Human immunodeficiency virus associated lymphomaJoseph A Sparano
Pageof 26